Skip to main content
. Author manuscript; available in PMC: 2018 Jul 26.
Published in final edited form as: Vaccine. 2012 Aug 20;30(45):6461–6471. doi: 10.1016/j.vaccine.2012.07.089

Table 1.

Influenza isolates characterized by hemagglutination inhibition assay by WHO Collaborating Centres (samples collected in March – August, 2011)

A(H1N1)pdm09a A(H3N2)b B/Victoriac B/Yamagatad
Total tested 1232 776 1770 598
Low reactors (% of total) 160 (3%) 40 (5%) 53 (3%) 0
a

Compared to the A/California/7/2009 vaccine virus

b

Compared to the A/Perth/16/2009 vaccine virus

c

Compared to the B/Brisbane/60/2008 vaccine virus

d

Compared to reference viruses B/Wisconsin/01/2010, B/Hubei-Wujiagang/158/2009 or B/Bangladesh/3333/2007